kidney disease glp 1 glp-1 news New Hope for Disease: Understanding Agonists Unlocking Cardio-Renal Protection: Breakthrough with – Glucagon-like peptide-1 receptor signaling modifies

Labeling update (2026): The FDA recently removed suicidal behavior and ideation language from the labeling of certain GLP-1 medicines used for chronic weight management, following a comprehensive safety review that found no evidence of increased risk

People mistake the diuretic effect for fat loss and end up in a cycle of yo-yo body water changes that can disrupt electrolyte balance. Harvard Health Publishing echoes that detox diets and alkaline water trends are marketing strategies, not science

It does, however, cover FDA-approved uses of GLP-1 medications for other conditions such as diabetes or cardiovascular disease even though weight loss is a secondary benefit

Its a great option for GLP-1 users who feel they need a little more support for regularity and smooth elimination